NCT00552500View on ClinicalTrials.gov

Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Insulin ResistanceBody Composition
Interventions
DRUG

Depakote (valproate)

500 mg -2000 mg QD based on individual tolerance and VPA levels

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00552500 - Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia | Biotech Hunter | Biotech Hunter